Latest European Markets News

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

Sprintex has advanced a promising trial with a major Dutch agribusiness, potentially unlocking €4.8 million in sales, while also securing a significant private-label contract in China’s booming aquaculture sector.

Firebird Metals has made significant strides in its lithium manganese iron phosphate (LMFP) battery strategy, unveiling a new lab-scale cathode production facility and securing key patents. The company also demonstrated major energy savings in kiln trials, positioning itself strongly in the evolving battery materials market.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Bindi Metals reports steady progress on its Lisa antimony-gold project in Serbia alongside promising gallium mineralisation at its Australian Biloela copper-gold project, maintaining a solid cash position.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.

International Graphite Limited is advancing its strategy to become a global mine-to-market industrial graphite company, with a new joint venture in Germany and expansion of its Western Australian operations targeting production by 2027.

International Graphite Limited (ASX – IG6) has had its trading suspension lifted following the announcement of a new agreement to develop a graphite processing facility in Europe.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.

Imricor Medical Systems reported significant regulatory and commercial progress in Q2 CY25, including CE mark approvals and expanded clinical trials, while maintaining a strong cash position.

Bioxyne Limited reports a record-breaking Q4 FY25 with revenue soaring 204% year-on-year and a strategic entry into the German market through a €3.2 million manufacturing agreement.